2,818 Shares in CVS Health Co. (NYSE:CVS) Purchased by Hyman Charles D

Hyman Charles D acquired a new position in shares of CVS Health Co. (NYSE:CVS) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,818 shares of the pharmacy operator’s stock, valued at approximately $222,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in shares of CVS Health by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock valued at $8,180,295,000 after acquiring an additional 485,744 shares in the last quarter. FMR LLC raised its holdings in shares of CVS Health by 29.1% in the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after acquiring an additional 6,194,441 shares in the last quarter. Northern Trust Corp raised its holdings in shares of CVS Health by 2.2% in the 3rd quarter. Northern Trust Corp now owns 14,214,296 shares of the pharmacy operator’s stock valued at $992,442,000 after acquiring an additional 305,564 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of CVS Health by 2.2% in the 3rd quarter. Royal Bank of Canada now owns 14,136,920 shares of the pharmacy operator’s stock valued at $987,041,000 after acquiring an additional 303,512 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of CVS Health by 1.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 12,950,289 shares of the pharmacy operator’s stock valued at $993,351,000 after acquiring an additional 232,464 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by company insiders.

CVS Health Trading Down 0.4 %

NYSE CVS traded down $0.23 on Tuesday, hitting $55.74. The company’s stock had a trading volume of 17,144,275 shares, compared to its average volume of 11,872,880. The firm has a market cap of $69.97 billion, a P/E ratio of 9.80, a PEG ratio of 0.88 and a beta of 0.56. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The company’s 50-day simple moving average is $71.95 and its 200 day simple moving average is $73.09. CVS Health Co. has a 52-week low of $53.70 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.20 EPS. Research analysts predict that CVS Health Co. will post 7.03 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.77%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is presently 46.75%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CVS. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and reduced their price objective for the company from $99.00 to $59.00 in a research report on Tuesday. Wells Fargo & Company reduced their price objective on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Bank of America reduced their price objective on CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Royal Bank of Canada reduced their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Finally, Mizuho reduced their price objective on CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Nine analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $77.55.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.